Who Owns TMED?

T ROWE PRICE ETF INC — Institutional Ownership & 13F Holdings

NASDAQ

$29.84

+0.06 (+0.20%)

Market Cap

Shares Outstanding

Institutional Holders

121

Total Inst. Value

$483.5M

% of Float Held

QoQ Holder Change

+60

Institutional data as of Q1 2025

New Positions

29

Closed Positions

13

Increased

42

Decreased

23

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Glenview Trust Co$65.7M1,560,592
2BANK OF AMERICA CORP /DE/$64.0M1,681,337
3Cetera Investment Advisers$59.9M1,571,439
4NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$58.1M1,524,205
5PRICE T ROWE ASSOCIATES INC /MD/$47.6M1,250,001
6Harbor Group, Inc.$15.3M402,025
7RAYMOND JAMES FINANCIAL INC$13.7M359,377
8Souders Financial Advisors$10.9M285,251
9Linscomb Wealth, Inc.$9.5M248,582
10Janney Montgomery Scott LLCNew$9.2M242,529

Biggest Buyers & Sellers This Quarter

Frequently Asked Questions

How many institutional investors hold TMED?

As of Q1 2025, 121 institutional investors report holding TMED (T ROWE PRICE ETF INC) in their 13F filings.

Which hedge fund owns the most TMED?

The largest institutional holder of TMED is Glenview Trust Co with $65.7M in shares.

Are institutions buying or selling TMED?

This quarter, 29 institutions opened new positions in TMED and 13 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.